(Q45218285)

English

Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.

scientific article published in March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

Sharon K Greene

object named as

Sharon K Greene

3

0 references

5

object named as

Grace M Lee

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Claudia Vellozzi

4

object named as

Claudia Vellozzi

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

author name string

Alison Tse

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Hung Fu Tseng

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

VSD Rapid Cycle Analysis Influenza Working Group

6

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

language of work or name

0 references

publication date

1 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

2024-2031

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

The Vaccine Safety Datalink project

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

The Vaccine Safety Datalink: a model for monitoring immunization safety

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Real-time vaccine safety surveillance for the early detection of adverse events

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Predictive value of seizure ICD-9 codes for vaccine safety research

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Lack of association between acellular pertussis vaccine and seizures in early childhood.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Register-based studies on febrile seizures in Denmark

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Risk of epilepsy after febrile convulsions: a national cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Incidence of febrile seizures in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Recurrence of febrile seizures in the respiratory season is associated with influenza A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Genetic and environmental factors in febrile seizures: a Danish population-based twin study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data from five studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Increased number of febrile seizures in children born very preterm: relation of neonatal, febrile and epileptic seizures and neurological dysfunction to seizure outcome at 16 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Fetal growth retardation and risk of febrile seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Seizure susceptibility due to antihistamines in febrile seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Influenza A infection is an important cause of febrile seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Relationship between five common viruses and febrile seizure in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Influenza A and febrile seizures in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Pediatric Neurologic Complications Associated With Influenza A H1N1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

The annual impact of seasonal influenza in the US: Measuring disease burden and costs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Population-wide benefits of routine vaccination of children against influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

The burden of influenza illness in children with asthma and other chronic medical conditions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Healthcare utilization and cost of pneumococcal disease in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Seasonal Patterns of Invasive Pneumococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Circadian and seasonal variation of first febrile seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Relationship between the population incidence of febrile convulsions in young children in Sydney, Australia and seasonal epidemics of influenza and respiratory syncytial virus, 2003-2010: a time series analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

The reporting sensitivities of two passive surveillance systems for vaccine adverse events

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.027

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.01.027

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45218285&oldid=1531261926"